Anzeige
Meldung des Tages: +52% am Freitag und das könnte erst der Anfang sein: Zefiro sichert sich millionenschwere Staatsaufträge

Klotho Neurosciences News

Aktie
WKN:  A40KLP ISIN:  US49876K1034 US-Symbol:  GRML Branche:  Biotechnologie Land:  USA
0,4212 $
+0,0136 $
+3,34%
0,35793 € 17.04.26
Depot/Watchlist
Marktkapitalisierung *
9,57 Mio. €
Streubesitz
76,14%
KGV
-
Index-Zuordnung
-

Klotho Neurosciences News

24.07.25 - PR Newswire
Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology
Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology PR Newswire
22.07.25 - PR Newswire
Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets
Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets PR Newswire
16.07.25 - PR Newswire
Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules
Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules PR Newswire
10.07.25 - PR Newswire
Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")
Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease") PR Newswire
30.06.25 - PR Newswire
Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS
Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS PR Newswire
30.06.25 - PR Newswire
Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS
Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS PR Newswire
24.06.25 - PR Newswire
Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population
Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the ...
24.06.25 - PR Newswire
Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population
Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the ...
18.06.25 - PR Newswire
KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMS
KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS ...
16.06.25 - PR Newswire
KLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT
KLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT PR Newswire
09.06.25 - PR Newswire
KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO ("α-KLOTHO")
KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-​KLOTHO ("α-...

Newssuche

Videos

newspaper
10:20 Uhr -1,94%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »